- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Senores Pharmaceuticals Ltd (SENO)
Senores Pharmaceuticals Ltd stock price live, this page displays NSE SENO stock exchange data. View the SENO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Senores Pharmaceuticals Ltd real time stock price chart below.
What Is the Senores Pharmaceuticals Ltd Stock Price Today?
The Senores Pharmaceuticals Ltd stock price today is 707.25.
What Is the Stock Symbol for Senores Pharmaceuticals Ltd?
The stock symbol for Senores Pharmaceuticals Ltd is ""SENO.""
What Stock Exchange Does Senores Pharmaceuticals Ltd Trade On?
Senores Pharmaceuticals Ltd is listed and trades on the NSE stock exchange.
Is Senores Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Senores Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SENO quote. (ISIN: INE0RB801010)
What Is the Senores Pharmaceuticals Ltd Stock Price Today?
The Senores Pharmaceuticals Ltd stock price today is 707.25.
What Is the Stock Symbol for Senores Pharmaceuticals Ltd?
The stock symbol for Senores Pharmaceuticals Ltd is ""SENO.""
What Stock Exchange Does Senores Pharmaceuticals Ltd Trade On?
Senores Pharmaceuticals Ltd is listed and trades on the NSE stock exchange.
Is Senores Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Senores Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SENO quote. (ISIN: INE0RB801010)
707.25
-10.60(-1.48%)
Closed·
Fair Value
An estimate of a Senores Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
703.35
725.90
52 wk Range
391.00
737.85
SENO Scorecard
Full Analysis
Net income is expected to grow this year
SENO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Senores Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
703.35725.90
52 wk Range
391.00737.85
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SENO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Senores Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
896.67
Upside
+26.78%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Senores Pharmaceuticals Ltd Company Profile
Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, Canada, and internationally. The company offers critical care pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimalarial, neutral supplements, and urinary tract generics; and management and consultancy services. Senores Pharmaceuticals Limited was incorporated in 2017 and is based in Ahmedabad, India.
Compare SENO to Peers and Sector
Metrics to compare | SENO | Peers Peers - average of corresponding metrics from companies closely matching SENO: STAR, CAPLIPOINT, AJANTPHARM, GLAND, APLLTD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSENOPeersSector |
|---|---|---|---|---|
P/E Ratio | 48.2x | 23.4x | −0.5x | |
PEG Ratio | - | 0.23 | 0.00 | |
Price/Book | 4.1x | 3.3x | 2.6x | |
Price / LTM Sales | 7.1x | 2.3x | 3.3x | |
Upside (Analyst Target) | 24.4% | 20.2% | 38.7% | |
Fair Value Upside | Unlock | 11.4% | 5.0% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 896.67
(+26.78% Upside)
Earnings
Latest Release
Jul 23, 2025
EPS / Forecast
4.30 / --
Revenue / Forecast
1.38B / --
People Also Watch
FAQ
What Stock Exchange Does Senores Pharmaceuticals Trade On?
Senores Pharmaceuticals is listed and trades on the India National Stock Exchange stock exchange.
What Is the Stock Symbol for Senores Pharmaceuticals?
The stock symbol for Senores Pharmaceuticals is "SENO."
What Is the Senores Pharmaceuticals Market Cap?
As of today, Senores Pharmaceuticals market cap is 31.10B.
What Is Senores Pharmaceuticals's Earnings Per Share (TTM)?
The Senores Pharmaceuticals EPS (TTM) is 17.26.
From a Technical Analysis Perspective, Is SENO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Senores Pharmaceuticals Stock Split?
Senores Pharmaceuticals has split 0 times.
How Many Employees Does Senores Pharmaceuticals Have?
Senores Pharmaceuticals has 0 employees.
What is the current trading status of Senores Pharmaceuticals (SENO)?
As of 27 Aug 2025, Senores Pharmaceuticals (SENO) is trading at a price of 707.25, with a previous close of 717.85. The stock has fluctuated within a day range of 703.35 to 725.90, while its 52-week range spans from 391.00 to 737.85.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.